✦ LIBER ✦

A phase II study of ifosfamide in advanced and relapsed carcinoma of the cervix

✍ Scribed by R. E. Coleman; P. G. Harper; C. Gallagher; R. Osborne; E. M. Rankin; A. C. Silverstone; M. L. Slevin; R. L. Souhami; J. S. Tobias; C. W. Trask; E. Wiltshaw

Publisher: Springer
Year: 1986
Tongue: English
Weight: 405 KB
Volume: 18
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00273403

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of ifosfamide and cispl

A phase II study of ifosfamide and cisplatin chemotherapy for metastatic or relapsed carcinoma of the cervix

✍ R. E. Coleman; J. M. Clarke; M. L. Slevin; J. Sweetenham; C. J. Williams; P. Bla 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 363 KB

Phase II study of ifosfamide and mesna i

Phase II study of ifosfamide and mesna in patients with previously-treated carcinoma of the cervix

✍ Gregory P. Sutton; John A. Blessing; Leon Adcock; Kenneth D. Webster; Timothy De 📂 Article 📅 1989 🏛 Springer US 🌐 English ⚖ 223 KB

A phase II study of ifosfamide in the tr

A phase II study of ifosfamide in the treatment of relapses in Wilms' tumor

✍ Marie France Tournade 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 202 KB

The purpose of this study was to evaluate the antitumor activity and tolerability of ifosfamide (IFO) at a dose of 3 g/m2, given on 2 consecutive days every 2 weeks, in advanced Wilms' tumor patients in whom conventional therapy had failed. Mesna and hyperhydration were concomitantly given to minimi

Phase II studies of ifosfamide alone and

Phase II studies of ifosfamide alone and in combination in cancer of the cervix

✍ G. Blackledge; E. J. Buxton; J. J. Mould; J. Monaghan; M. Paterson; J. Tobias; C 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 543 KB

A Phase II study of paclitaxel-ifosfamid

A Phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma

✍ Christos Kosmas; Nicolas B. Tsavaris; Aristidis Polyzos; Haralambos P. Kalofonos 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

A Phase II study of paclitaxel and ifosf

A Phase II study of paclitaxel and ifosfamide for patients with advanced refractory carcinoma of the urothelium

✍ Christopher J. Sweeney; Stephen D. Williams; David E. Finch; Richard Bihrle; Ric 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 2 views

## BACKGROUND. Cisplatin-based combination chemotherapy for patients with advanced transitional cell carcinoma (TCC) of the urothelium has limitations, and new therapies need to be evaluated. METHODS. Ifosfamide 1.0 gm/m 2 on Days 1-4 and paclitaxel 135 mg/m 2 by 24-hour infusion on Day 4 were ad